Cargando…

Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice

Detalles Bibliográficos
Autores principales: Ai, Yongqiang, Shi, Wei, Zuo, Xiaobin, Sun, Xiaoming, Chen, Yuanyuan, Wang, Zhilei, Li, Ruisheng, Song, Xueai, Dai, Wenzhang, Mu, Wenqing, Ding, Kaixin, Li, Zhiyong, Li, Qiang, Xiao, Xiaohe, Zhan, Xiaoyan, Bai, Zhaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529232/
https://www.ncbi.nlm.nih.gov/pubmed/34690790
http://dx.doi.org/10.3389/fphar.2021.777914
_version_ 1784586425880018944
author Ai, Yongqiang
Shi, Wei
Zuo, Xiaobin
Sun, Xiaoming
Chen, Yuanyuan
Wang, Zhilei
Li, Ruisheng
Song, Xueai
Dai, Wenzhang
Mu, Wenqing
Ding, Kaixin
Li, Zhiyong
Li, Qiang
Xiao, Xiaohe
Zhan, Xiaoyan
Bai, Zhaofang
author_facet Ai, Yongqiang
Shi, Wei
Zuo, Xiaobin
Sun, Xiaoming
Chen, Yuanyuan
Wang, Zhilei
Li, Ruisheng
Song, Xueai
Dai, Wenzhang
Mu, Wenqing
Ding, Kaixin
Li, Zhiyong
Li, Qiang
Xiao, Xiaohe
Zhan, Xiaoyan
Bai, Zhaofang
author_sort Ai, Yongqiang
collection PubMed
description
format Online
Article
Text
id pubmed-8529232
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85292322021-10-22 Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice Ai, Yongqiang Shi, Wei Zuo, Xiaobin Sun, Xiaoming Chen, Yuanyuan Wang, Zhilei Li, Ruisheng Song, Xueai Dai, Wenzhang Mu, Wenqing Ding, Kaixin Li, Zhiyong Li, Qiang Xiao, Xiaohe Zhan, Xiaoyan Bai, Zhaofang Front Pharmacol Pharmacology Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529232/ /pubmed/34690790 http://dx.doi.org/10.3389/fphar.2021.777914 Text en Copyright © 2021 Ai, Shi, Zuo, Sun, Chen, Wang, Li, Song, Dai, Mu, Ding, Li, Li, Xiao, Zhan and Bai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ai, Yongqiang
Shi, Wei
Zuo, Xiaobin
Sun, Xiaoming
Chen, Yuanyuan
Wang, Zhilei
Li, Ruisheng
Song, Xueai
Dai, Wenzhang
Mu, Wenqing
Ding, Kaixin
Li, Zhiyong
Li, Qiang
Xiao, Xiaohe
Zhan, Xiaoyan
Bai, Zhaofang
Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
title Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
title_full Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
title_fullStr Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
title_full_unstemmed Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
title_short Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
title_sort corrigendum: the combination of schisandrol b and wedelolactone synergistically reverses hepatic fibrosis via modulating multiple signaling pathways in mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529232/
https://www.ncbi.nlm.nih.gov/pubmed/34690790
http://dx.doi.org/10.3389/fphar.2021.777914
work_keys_str_mv AT aiyongqiang corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT shiwei corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT zuoxiaobin corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT sunxiaoming corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT chenyuanyuan corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT wangzhilei corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT liruisheng corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT songxueai corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT daiwenzhang corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT muwenqing corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT dingkaixin corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT lizhiyong corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT liqiang corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT xiaoxiaohe corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT zhanxiaoyan corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice
AT baizhaofang corrigendumthecombinationofschisandrolbandwedelolactonesynergisticallyreverseshepaticfibrosisviamodulatingmultiplesignalingpathwaysinmice